Literature DB >> 23582061

Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.

Guobing Chen1, M Shannon.   

Abstract

Experimental autoimmune encephalomyelitis (EAE), a widely studied animal model of human central nervous system demyelinating diseases such as multiple sclerosis, is a T-cell-mediated autoimmune disease involving effector T helper (Th) subsets such as Th and Th7. Recently, Th7 cells have been shown to play a major role in many autoimmune and other inflammatory diseases. The development of Th subsets is controlled by a complex network of cytokines and signaling and transcription molecules that act to augment the development of one cell type while restricting the development of other lineages. Here, we review the transcription factors (TFs) that are required for Th17 cell development in EAE and classify them into three types: major or essential such as RORγt and STAT3, an array of helper factors that work in combination with or regulate the expression of the major factors, and regulatory TFs that attenuate the expression of Th17 genes. The plasticity of the Th17 cell lineage is also discussed in relation to the interaction of TFs that play a major role in the development of other Th or regulatory T cell (Treg) lineages such as T-bet and Foxp3 with the Th17 TFs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23582061     DOI: 10.1615/critrevimmunol.2013006959

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  8 in total

Review 1.  Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.

Authors:  Mikhail Melnikov; Vladimir Rogovskii; Alexey Boykо; Mikhail Pashenkov
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

2.  Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus.

Authors:  Jennifer L H Wheeler; Kyle C Martin; Emily Resseguie; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2013-11-05       Impact factor: 4.849

3.  Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.

Authors:  Weimin Kong; Hongbo Li; Ronald F Tuma; Doina Ganea
Journal:  Cell Immunol       Date:  2013-11-14       Impact factor: 4.868

4.  Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.

Authors:  Sijo V Chemmannur; Prasad Bhagat; Bhalchandra Mirlekar; Kishore M Paknikar; Samit Chattopadhyay
Journal:  Int J Nanomedicine       Date:  2016-05-12

5.  Potential involvement of glycogen synthase kinase (GSK)-3β in a rat model of multiple sclerosis: evidenced by lithium treatment.

Authors:  Meejung Ahn; Jeongtae Kim; Changnam Park; Jinhee Cho; Youngheun Jee; Kyungsook Jung; Changjong Moon; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2017-03-29

6.  Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis.

Authors:  Zhi-Hui Li; Yi-Fei Wang; Dan-Dan He; Xue-Mei Zhang; Ying-Lian Zhou; Hui Yue; Shan Huang; Zheng Fu; Ling-Yu Zhang; Zhu-Qing Mao; Shuang Li; Chen-Yu Zhang; Xi Chen; Jin Fu
Journal:  Aging (Albany NY)       Date:  2019-07-15       Impact factor: 5.682

7.  Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Lanfang Zhang; Yixian Guo; Chang-Qing Xia
Journal:  J Immunol Res       Date:  2015-07-14       Impact factor: 4.818

8.  TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation.

Authors:  Suzanne Speck; James Lim; Sagar Shelake; Marsel Matka; Jonathan Stoddard; Alexander Farr; Vijay Kuchroo; Yasmina Laouar
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.